Membrane post treatment

Information

  • Patent Grant
  • 8262778
  • Patent Number
    8,262,778
  • Date Filed
    Wednesday, August 10, 2011
    12 years ago
  • Date Issued
    Tuesday, September 11, 2012
    11 years ago
Abstract
The invention relates to polymeric ultrafiltration or microfiltration membranes of, for instance, poly(ethylene chlorotrifluoroethylene) (HALAR®), PVDF or PP, incorporating PVME or vinyl methyl ether monomers. The PVME may be present as a coating on the membrane or dispersed throughout the membrane or both. The membranes are preferably hydrophilic with a highly asymmetric structure with a reduced pore size and/or absence of macrovoids as a result of the addition of PVME. The PVME maybe cross-linked. The invention also relates to methods of hydrophilising membranes and/or preparing hydrophilic membranes via thermal or diffusion induced phase separation processed.
Description
FIELD OF THE INVENTION

The invention relates to compositions and methods for the hydrophilisation of membranes, particularly hollow fibre membranes for use in microfiltration and ultrafiltration. The invention also relates to membranes prepared in accordance with these methods.


BACKGROUND ART

The following discussion is not to be construed as an admission with regard to the common general knowledge.


Synthetic membranes are used for a variety of applications including desalination, gas separation, filtration and dialysis. The properties of the membranes vary depending on the morphology of the membrane i.e. properties such as symmetry, pore shape and pore size and the polymeric material used to form the membrane.


Different membranes can be used for specific separation processes, including microfiltration, ultrafiltration and reverse osmosis. Microfiltration and ultrafiltration are pressure driven processes and are distinguished by the size of the particle or molecule that the membrane is capable of retaining or passing. Microfiltration can remove very fine colloidal particles in the micrometer and sub micrometer range. As a general rule, microfiltration can filter particles down to 0.1 μm, whereas ultrafiltration can retain particles as small as 0.01 μm and smaller. Reverse Osmosis operates on an even smaller scale.


As the size of the particles to be separated decreases, the pore size of the membrane must decrease and the pressure required to carry out the separation increases.


A large surface area is needed when a large filtrate flow is required. One known technique to make filtration apparatus more compact is to form a membrane in the shape of a hollow porous fibre. Modules of such fibres can be made with an extremely large surface area per unit volume.


Microporous synthetic membranes are particularly suitable for use in hollow fibres and are produced by phase inversion. In this process, at least one polymer is dissolved in an appropriate solvent and a suitable viscosity of the solution is achieved. The polymer solution can be cast as a film or hollow fibre, and then immersed in a precipitation bath such as water. This causes separation of the homogeneous polymer solution into a solid polymer and liquid solvent phase. The precipitated polymer forms a porous structure containing a network of uniform pores. Production parameters that affect the membrane structure and properties include the polymer concentration, the precipitation media and temperature and the amount of solvent and non-solvent in the polymer solution. These factors can be varied to produce microporous membranes with a large range of pore sizes (from less than 0.1 to 20 μm), and altering chemical, thermal and mechanical properties.


Microporous phase inversion membranes are particularly well suited to the application of removal of viruses and bacteria. Of all types of membranes, the hollow fibre contains the largest membrane area per unit volume.


Flat sheet membranes are prepared by bringing a polymer solution consisting of at least one polymer and solvent into contact with a coagulation bath. The solvent diffuses outwards into the coagulation bath and the precipitating solution will diffuse into the cast film. After a given period of time, the exchange of the non-solvent and solvent has proceeded such that the solution becomes thermodynamically unstable and de-mixing occurs. Finally a flat sheet is obtained with an asymmetric or symmetric structure.


Hydrophobic surfaces are defined as “water hating” and hydrophilic surfaces as “water loving”. Many of the polymers used in the manufacture of porous membranes are hydrophobic polymers. Water can be forced through a hydrophobic membrane, but usually only under very high pressure (150-300 psi). Membranes may be damaged at such pressures and under these circumstances generally do not become wetted evenly.


Hydrophobic microporous membranes are characterised by their excellent chemical resistance, biocompatibility, low swelling and good separation performance. Thus, when used in water filtration applications, hydrophobic membranes need to be hydrophilised or “wet out” to allow water permeation. Some hydrophilic materials are not suitable for microfiltration and ultrafiltration membranes that require mechanical strength and thermal stability since water molecules present in the polymer can play the role of plasticizers.


Currently, poly(tetrafluoroethylene) (PTFE), Polyethylene (PE), Polypropylene (PP) and poly(vinylidene fluoride) (PVDF) are the most popular and available hydrophobic membrane materials. Poly(ethylene-chlorotrifluoroethylene) sold under the trademark HALAR® is another hydrophobic material showing promise as a membrane polymeric material.


Poly(vinylidene fluoride) (PVDF) is a semi-crystalline polymer containing a crystalline phase and an amorphous phase. The crystalline phase provides good thermal stability whilst the amorphous phase adds some flexibility to the membrane. PVDF exhibits a number of desirable characteristics for membrane applications, including thermal resistance, reasonable chemical resistance (to a range of corrosive chemicals, including sodium hypochlorite), and weather (UV) resistance.


While PVDF has to date proven to be one of the most desirable options from among those materials suitable for microporous membranes, the search continues for membrane materials which will provide better chemical stability and performance while retaining the desired physical properties required to allow the membranes to be formed and worked in an appropriate manner.


Given the good membrane forming properties of hydrophobic membranes and their favourable mechanical and chemical properties, as well as the general familiarity in the industry with such materials, one approach to hydrophilic membranes is to synthesise membranes based around a hydrophobic polymer but with modification of the hydrophobic/hydrophilic balance of the membrane. The two main modes of modifying membrane property are (i) to modify the starting materials, reagents or conditions used to produce the membrane or (ii) to modify the membrane after production (post-treatment). Combinations of the two approaches are also possible, for example, introducing components into a membrane which alone may not alter membrane function, but which do interact with reagents subsequently applied to produce a membrane with a modified property.





BRIEF DESCRIPTION OF THE FIGURES


FIG. 1 depicts the results of leaching tests for PVME in accordance with the present invention.



FIGS. 2 and 3 depict the differences between the structures of PVDF membranes for samples with and without PVME.



FIG. 4 illustrates demixing in the case of HALAR® membranes.



FIG. 5 depicts a decrease in the formation of macrovoids due to the addition of PVME.





DESCRIPTION OF THE INVENTION

The present applicants have found that, in certain cases, Poly(VinylMethylEther) (PVME) can be used to modify, and in particular, reduce, the hydrophobicity of certain hydrophobic membranes. The PVME can be incorporated either by means of post-treatment, such as by soaking hollow-fibre membranes in a solution of PVME, or by incorporating PVME into the dope solution for forming the membrane. Either approach could be demonstrated for a variety of reaction types, including different types of membranes such as Poly(vinylidene fluoride) (PVDF), Poly(ethylene-chlorotrifluoroethylene) sold under the trademark HALAR® and Poly(propylene) (PP).


PVME as a post-treatment was found to make PVDF and Poly(ethylene-chlorotrifluoroethylene) (sold under the trademark HALAR®) membranes hydrophilic, although the treatment was also useful on PP membranes.


PVME as a membrane additive was found to induce variations in the pore structure of PVDF such as asymmetry, as well as to impart hydrophilicity to the final membrane. This was apparent for both TIPS and DIPS methods of making a membrane.


As used herein, PVME also encompasses not only the polymeric form of the product, but also the monomeric form of the compound, namely vinylmethyl ether, as well as di-, tri-, and oligomeric forms.


SUMMARY

According to a first aspect, the invention provides a polymeric ultra or microfiltration membrane incorporating PVME. The polymeric ultra or microfiltration membrane may incorporate a coating of PVME or, alternatively include a homogeneous dispersion of PVME throughout the polymer or both.


The polymeric membrane may include a heterogeneous dispersion of PVME throughout the polymer.


In another aspect, the invention provides a hydrophilic polymeric membrane including one or more of Poly(ethylene-chlorotrifluoroethylene) sold under the trademark HALAR®, PVDF or PP.


In yet another aspect, the invention provides a hydrophilic polymeric membrane having a highly asymmetric structure, preferably formed from one or more of Poly(ethylene-chlorotrifluoroethylene) sold under the trademark HALAR®, PVDF or PP.


Preferably the membrane has a reduced pore size as a result of the addition of PVME. Preferably also, the membrane is substantially free from macrovoids.


Preferably, the membrane according to the present invention contains cross linked PVME. The membrane according to the present invention may incorporate adsorbed PVME and embedded PVME and wherein adsorbed PVME is cross-linked with embedded PVME.


Preferably the polymeric ultra or microfiltration membranes of the present invention contain PVDF and PVME in a ratio of 0.1:24 to 0.5 to 24, more preferably in a ratio of 0.5:18 to 1:18 and even more preferably in a ratio of 0.4:13 to 2.3:13.


The polymeric ultra or microfiltration membranes preferably contain 0.4 to 30 wt % PVME.


In one embodiment, polymeric ultra or microfiltration membranes of the present invention on soaking for 8 hours produce a detectable quantity of PVME, or for example, on soaking for 48 hours produces a leachate having at least 5 ppm PVME.


Preferably the hydrophobic polymeric ultra or microfiltration membranes are rendered hydrophilic by contacting the membrane with an aqueous or alcoholic solution of PVME with a concentration 0.05 to 5 wt %. More preferably, the polymeric ultra or microfiltration membranes are rendered hydrophilic by contacting the membrane with an aqueous or alcoholic solution of PVME with a concentration of 0.05 to 5 wt %, at a pressure of 0.5 to 50 bar.


According to a second aspect, the invention provides a method of hydrophilising a membrane prepared from a polymeric material, said method including the step of contacting said polymeric material with a compatible at least partially water soluble polymeric hydrophilising agent.


Preferably, the at least partially water soluble polymeric hydrophilising agent is soluble in an amount of at least 5-10 g/l at standard temperature and pressure.


Preferably, the at least partially water soluble polymeric hydrophilising agent contains vinylmethyl ether monomers. More preferably, the polymeric hydrophilising agent is polyvinylmethyl ether (PVME).


The polymeric hydrophilising agent may be a copolymer containing vinylmethyl ether monomer and at least one other co-monomer. It is preferred that the vinylmethyl ether monomer is present in an amount of at least 50 mole % of the polymeric hydrophilising agent.


If a co monomer is used, it is preferred if the co-monomer is selected from the group consisting of: co-polymerisable acrylate monomers and co-polymerisable vinyl monomers.


More preferably, the co-monomer is selected from the group consisting of: vinyl acetate, acrylic acid, methyl acrylate, methyl methacrylate, allyl methacrylate, ethyl acrylate, ethyl methacrylate, methacrylic acid, fumaric acid, monoesters of fumaric acid, diesters of fumaric acid, maleic acid, monoesters of maleic acid, diesters maleic acid, diallyl maleate maleic anhydride, esters of adipic acid (divinyl adipate), ethylenically unsaturated carboxamides (acrylamide), ethylenically unsaturated carbo-nitriles (acrylonitrile), ethylenically unsaturated sulfonic acids (vinylsulfonic acid).


According to a third aspect the invention provides a method of modifying the hydrophobic/hydrophilic balance of a polymer membrane prepared from a polymeric material, said method including the step of contacting said polymeric material with polyvinylmethyl ether (PVME) to produce a modified polymeric membrane.


Preferably the polymeric membrane is coated with PVME.


The membrane may be in the form of an ultrafiltration membrane or a microfiltration membrane.


In one preferred embodiment, the polymeric material is a hydrophobic polymer and hydrophobic/hydrophilic balance of the polymer is modified to provide a hydrophilic modified polymeric membrane.


For preference, the polymeric material is poly(vinylidene fluoride) (PVDF), poly(ethylene-chlorotrifluoroethylene) sold under the trademark HALAR® and poly(propylene) (PP) or mixtures thereof. Poly(vinylidene fluoride) (PVDF) and poly(ethylene-chlorotrifluoroethylene) sold under the trademark HALAR® are particularly preferred.


The polymeric material may be a formed membrane treated with a solution of PVME. Preferably, the polymeric material is treated with a solution of PVME at a concentration and for a time sufficient to allow PVME saturation of said membrane to take place. In one preferred embodiment, the polymeric material is post treated by soaking in a solution of PVME in ethanol. In another preferred embodiment, the polymeric material is post treated by soaking in a solution of PVME in water.


It is preferred that the concentration of PVME is less than 10%, more preferably less than 5% and even more preferably less than 3%, however it is preferred that the concentration of PVME is greater then 0.1%.


A range of 1 to 5% is particularly preferred.


It is preferred that treatment with PVME takes place for between 5 minutes and 16 hours. Preferably, such treatment with a solution of PVME is followed by a rinsing stage to remove unbound PVME.


In an alternative embodiment, the polymeric material is treated with PVME by means of adding PVME to a membrane dope prior to casting. The membrane dope may be cast via a thermally induced phase separation process or by a diffusion induced phase separation process.


Preferably, the membrane dope includes PVME in an amount up to 1 wt % when a TIPS process is employed, or higher if a DIPS process is used. Preferably, the PVME is dissolved in a polymer dope/solvent/non-solvent mixture. More preferably, the solvent/non-solvent mixture includes a PVME solvent and PVME non-solvent.


Preferably, the PVME solvent possesses weak polarity, for example, glyceroltriacteate. Preferably, the PVME non-solvent is strongly polar, for example, diethylene glycol, triethylene glycol, 1,4-butanediol or mixtures thereof.


Preferably, the solvent mixture includes from 40-60% non-solvent.


Preferably, the solvent mixture includes PVME in an amount of 0.1-2 wt %, and more preferably in an amount of 0.7-1 wt %.


Preferably, when the method of casting is a TIPS process, it further includes treatment with a coating solution which most preferably contains a solvent and a non-solvent. When a DIPS process is used, it is preferred that N-methylpyrrolidone is present as a solvent, and water is present as non-solvent.


The present invention also provides a method wherein PVME is incorporated in the membrane dope and formed into a membrane, and wherein said membrane is further treated with PVME, for example the membrane is treated to cross-link incorporated and adsorbed PVME. A preferred method of cross linking is e-beam irradiation.


PVME readily cross-links upon irradiation with electron beams or γ-radiation and is of very low toxicity, as are the starting vinyl methyl ether monomer and its degradation products. This makes it a suitable candidate for many applications requiring biocompatibility. Further, despite already possessing a low toxicity, the starting vinyl ether monomer is readily hydrolysed at pH 7 or below and so can be readily removed, reducing even further any risk of membrane contamination by residual monomer.


PVME was surprisingly found to be effective at hydrophilising otherwise hydrophobic PP, PVDF and Poly(ethylene-chlorotrifluoroethylene) (sold under the trademark HALAR®) membranes either by soaking the membrane as a post treatment or by including the PVME as a hydrophilising agent incorporated in the membrane dope. Hydrophilisation can be achieved either by soaking the membranes in a solution of PVME in a suitable solvent, for example, ethanol or water, preferably at a level greater than 0.5 wt %. PVDF and Poly(ethylene-chlorotrifluoroethylene) (sold under the trademark HALAR®) membranes in particular demonstrate long term stability with PVME adsorbed onto the surface, although PVME also appears to have good affinity with PP. Leaching tests show minimal leaching of PVME from the membranes after 10 days with the PVDF and Poly(ethylene-chlorotrifluoroethylene) (sold under the trademark HALAR®) samples are all still hydrophilic after this period of time.


Including PVME into the dope via a TIPS process was also successful in imparting hydrophilicity to the membranes. The proportion of PVME in the dope was most preferably between 0.1 and 0.5%, although this is dependent upon the amount of non-solvent in the dope. If the proportion of non-solvent used was lower than 60 wt % a larger amount of PVME could be incorporated into the dope. Surprisingly, it was found that the introduction of PVME into membrane dope induced structural changes in the membranes, such as increased asymmetry and smaller pores in addition to imparting hydrophilicity to the membrane.


PVME could also be successfully incorporated into the dope via a DIPS process. As well as modifying the hydrophilic/hydrophobic balance, the presence of PVME significantly altered the base PVDF membrane structure and suppressed the formation of macrovoids. In the case of the DIPS process, it was found desirable to employ higher concentrations of PVDF as well as higher concentrations of PVME to achieve a high permeability membrane with good virus/dextran retention.


PVME modified membranes can be further modified, for example, by irradiation with electrons (e-beam). PVME is cross-linkable and under irradiation will cross-link on the membrane surface. Irradiation can be applied either to membranes that have been post-treated in PVME or to membranes that have had PVME included in the dope. PVME may, under appropriate conditions, also cross-link with PVDF when this is present in the membrane matrix.


PVDF and fluoropolymers with a similar structure (e.g. PVC, PVF, and PVDC) are known to undergo some cross-linking upon irradiation with electrons or γ-radiation and similar crosslinking with PVME is also possible. Those skilled in the art will appreciate that when γ-radiation is used on fluoropolymers, caution must be taken because there is possibility of chain scission (degradation).


Membranes with a cross-linkable hydrophilising agent in the dope may also be post-treated with additional cross-linkable agent (which may be the same or different to that used in the dope) and subsequently exposed to e-beam. This allows the adsorbed crosslinkable agent to cross-link with the embedded PVME agent, reducing the opportunity for the former to be desorbed from the surface.


A specific example of this is the preparation of membranes incorporating PVME in the dope which are also to be post-treated with an aqueous PVME solution and subsequently exposed to e-beam irradiation. Without wishing to be bound by theory, it is believed that this allows adsorbed PVME to cross-link with embedded PVME and be anchored to the surface of the membrane, reducing the opportunity for the PVME to be desorbed from the surface and dissolve into solution.


EXAMPLES
Post Treatment Studies

The post-treatment of a variety of membranes with a cross-linkable hydrophilising agent was investigated. PVDF, Poly(ethylene-chlorotrifluoroethylene) (sold under the trademark HALAR®) and PP membranes were all tested. For the Poly(ethylene-chlorotrifluoroethylene) (sold under the trademark HALAR®) membranes, both MF (microfiltration) and UF (ultrafiltration) membranes were tested.


The general procedure for treating the pre-prepared PP and PVDF membranes was as follows:


The dry membrane was soaked in a PVME (Lutonal M40) solution with, solvent, concentration and soaking time as specified. The membrane was subsequently removed from the PVME solution and placed into wash water for 4 hrs. The membrane was then dried for about 4 hrs.


The membrane was then tested for the ‘wicking’ of an aqueous solution of dye and the permeability of the fibre was also tested.


A sample of the membrane was then soaked in water at 65° C. for 1 hr and the permeability of the heat-treated membrane was also tested.


The general procedure for treating the pre-prepared Poly(ethylene-chlorotrifluoroethylene) (sold under the trademark HALAR®) membranes was more elaborate due to glycerol-loaded pores which are present as a result of the method of production of Poly(ethylene-chlorotrifluoroethylene) (sold under the trademark HALAR®) membranes. The membrane was soaked in ethanol for 12 hrs, followed by water for 15 minutes.


The membrane was then soaked in a PVME (Lutonal M40) solution with, solvent, concentration and soaking time as specified. The membrane was subsequently removed from the PVME solution and placed into wash water for 4 hrs. The membrane was then dried for about 4 hrs before being resoaked in an aqueous solution of 20 wt % glycerol for 16 hr to reload the pores. The membrane was then dried for 24 hr and the permeability of the standard untreated and treated membranes was tested.


All fibres were treated as described, with various concentrations of PVME and for varying lengths of time. Tables 1-3 below give the results from each variation of each fibre tested.


Wicking is said to have occurred if a solution of dye is spontaneously absorbed into a fibre that is partially submerged vertically in such a solution and travels upwards above the solution meniscus. This can clearly be seen in strongly hydrophilic fibres (capillary action) but not in hydrophobic fibres. Wicking tests were not conducted with the Poly(ethylene-chlorotrifluoroethylene) (sold under the trademark HALAR®) fibres, as an artificial result would arise as a result of the glycerol in the pores.









TABLE 1







PVDF - Wicking and Permeability results









Fibre Type













PVDF
PVDF
PVDF
PVDF
PVDF



MF
MF
MF
MF
MF





Solution
Ethanol
3 wt %
1 wt %
0.5 wt %
0.1 wt %


Details
wet
PVME
PVME
PVME
PVME




In Ethanol
In Water
In Water
In Water


Treatment
5 min
5 min
16 hr
16 hr
16 hr


Time







Break
 77
 79
 79
 79



Extension (%)







Fibre wicking?
No
Yes
Yes
Yes
No


Permeability
1632
1966
1521
1494
No flux


after PVME







treatment







(LMH/bar)







Permeability
1632
1442
1635
1551
No flux


after 65° C.







water soak







(LMH/bar)









The results in Table 1 demonstrate that PVDF is made hydrophilic by PVME post-treatment. Different concentrations of PVME (0-3 wt %) in water or in ethanol were investigated. The concentration of PVME in solution appears unimportant provided it is above a certain critical value, which is believed to be about 0.1%. There would appear to be little benefit in using more than 0.5% PVME. It is postulated that this may be dependent upon the fibre density in the solution, or in other words the ratio of available membrane surface area to free solution, since if PVME is adsorbing to the membrane surface there is a minimum PVME quantity in solution required to obtain a totally hydrophilic membrane surface. There will simply be no room on the membrane surface for any excess PVME to adsorb and as a consequence will be washed out of the membrane upon filtration.


If too little PVME is added, the surface may not be completely hydrophilic which may in turn affect complexing and linking.









TABLE 2







PP - Wicking and Permeability results











Fibre Type
PP MF
PP MF
PP MF
PP MF





Solution
Ethanol
1 wt %
1 wt %
0.5 wt %


Details
wet
PVME
PVME
PVME




In Ethanol
In Water
In Water


Treatment
5 min
5 min
16 hr
16 hr


Time






Fibre wicking?
No
Yes
No
No


Permeability
2726
1399
No Flux
No flux


(LMH/bar)






Retreated
2726
1442
No flux
No flux


Permeability






(LMH/bar)









The results in Table 2 show that PP can be made hydrophilic as demonstrated by wicking (see column 2 of Table 2) but the permeability is only about half that of the standard untreated PP membrane fibre.


It appears from these results that the interaction of PP with PVME is not the same as the interaction between PVDF and PVME. Without wishing to be bound by theory, it is postulated that the PVME is more strongly attracted to the PVDF surface that is slightly polar, rather than the PP surface which may be considered entirely non-polar. It seems that this affinity may be the effect that is dominating rather than that PVME is simply attracted to a hydrophobic surface in preference over solution in water.









TABLE 3







Poly(ethylene-chlorotrifluoroethylene) (sold under the trademark


HALAR ®) - Wicking and Permeability results









Fibre Type












HALAR ®
HALAR ®
HALAR ®
HALAR ®



MF
MF
UF
UF





Solution
Ethanol
2 wt %
Ethanol
2 wt %


Details
wet
PVME
wet
PVME




In Water

In Water


Treatment
5 min
16 hr
5 min
16 hr


Length






Permeability
2039
1620
527
289


(LMH/bar)









The permeability of Halar Poly(ethylene-chlorotrifluoroethylene) sold under the trademark HALAR® is slightly reduced as a result of PVME treatment. Generally permeability measurements for Poly(ethylene-chlorotrifluoroethylene) (sold under the trademark HALAR®) MF fibre range between 1500-2000 LMH/bar, with Poly(ethylene-chlorotrifluoroethylene) (sold under the trademark HALAR®) UF membranes varying between 200-600 LMH/bar.


The results from the Poly(ethylene-chlorotrifluoroethylene) (sold under the trademark HALAR®) membranes are difficult to quantify with precision because it is believed that glycerol in the pores results in lower initial clean water permeabilities that slowly increase towards a fixed value as the glycerol is completely removed from the pores. This may explain why the ethanol washed fibres have a slightly higher apparent permeability, since glycerol is more readily soluble in ethanol than in water.


Poly(ethylene-chlorotrifluoroethylene) (sold under the trademark HALAR®) has a mildly polar structure not dissimilar to PVDF and the affinity between HALAR® and PVME replicate to a degree the interaction between PVME and PVDF. The results below give an indication of the permanency of the treatment of Poly(ethylene-chlorotrifluoroethylene) (sold under the trademark HALAR®) membranes with PVME.


Wicking can clearly be seen in strongly hydrophilic fibres (capillary action) but not in hydrophobic fibres.


The leaching tests (FIG. 1) show that the PVME is leached out initially at a high rate but this reduces over time until eventually a stable solution concentration is achieved.


Leaching tests were conducted by soaking the fibres in reverse osmosis (RO) water for 240 hrs. The leach water was refreshed every 24 hours (the wash water being replaced a total of 9 times) and an aliquot was analysed by UV-Vis absorption and compared against a PVME calibration curve. The results above show that there is an immediate decline in the detection of PVME which this occurs for both wet and dry standards as well as for all samples. The biggest decline comes from the samples soaked in PVME, while of these samples the fibres soaked in 1 wt % ethanolic PVME have the lowest starting concentration. The general trend appears to be that some PVME leaches out immediately but after approximately 48 hrs there is no significant change in the PVME level in the wash water compared to the standard. As described above however, the change in the concentration cannot be considered significant compared to the standards on the basis of this examination.


The dry standard appears at first to increase in PVME concentration initially, to a concentration that is above the sample soaked in 1 wt % ethanolic PVME and the Poly(ethylene-chlorotrifluoroethylene) (sold under the trademark HALAR®) sample.


An ethanol-wet standard and a dry standard were both used because there can be very small quantities of residual solvent in the PVDF membranes that are only slightly soluble in water and although very difficult to leach out entirely would nevertheless affect the UV-Vis readings. Washing with ethanol prior to UV-Vis analysis should remove any residual solvent from the membrane. This may explain why the PVDF samples appear to rise in PVME leach concentration or have a slightly higher steady-state value rather than the ethanol-wet sample. However, it is also possible that the PVME may bind more firmly to the Poly(ethylene-chlorotrifluoroethylene) (sold under the trademark HALAR®) surface rather than the PVDF surface, from an aqueous solution.


The permeabilities of a number of membranes before and after PVME treatment are shown in Table 4.


In order to test the permeability after leaching, the fibres were removed from the RO water and dried at room temperature. The standard (non-treated) fibres were wet with ethanol prior to testing the permeability, while the treated fibres were simply tested with water. The results for permeability show that the fibres are still hydrophilic after this period of leaching, but that the permeabilities have dropped noticeably. This is a relatively uniform drop however and is between 40-55% across all samples including the standards, with the exception of the samples soaked in 1 wt % aqueous PVME.









TABLE 4







MEMBRANE PERMEABILITY BEFORE


AND AFTER PVME TREATMENT











Permeability
Permeability
%


Description
Before
After
Change













Ethanol washed Blank -
1542
984
−36.2


PVDF





1 wt % PVME in Ethanol -
1442
855
−40.7


PVDF





1 wt % PVME in Water -
1505
307
−79.8


PVDF





Dry Blank -

  1542a

741
−51.9


PVDF





1 wt % PVME in Water -
 138
74
−46.4


HALAR ®






aSince the dry blank was NOT to be treated with ethanol (including wetting out), it was assumed that the permeabilities for the two standard samples are identical, since they are obtained from the same source.







Soaking PVDF fibre membranes in PVME did not appear to modify the mechanical properties of any of the samples in any way. Treated membranes demonstrated the same break extensions as untreated samples.


Dope Addition Studies


TIPS Membranes


PVME was added to standard TIPS PVDF or TIPS Poly(ethylene-chlorotrifluoroethylene) (sold under the trademark HALAR®) dope in proportions varying from 0 to 1 wt %. The TIPS extrusion was operated in a continuous process (although there is nothing to prohibit its use in batch processes if desired). For PVDF, PVME was dissolved into the solvent/non-solvent mixture of GTA and diethylene glycol, triethylene glycol or 1,4-butanediol. For Poly(ethylene-chlorotrifluoroethylene) (sold under the trademark HALAR®), PVME was simply dissolved in GTA. PVME is highly soluble in GTA but insoluble in more polar compounds like diethylene glycol, triethylene glycol and 1,4-butanediol.


Because this mixture was between 40-60 wt % non-solvent, there was a maximum amount of PVME that could be dissolved into the solvent/non-solvent mixture (approx. 0.7 wt %). However, membranes formed with this proportion of PVME gave SEMs that suggested some de-mixing of PVDF was occurring. Thus, in most circumstances, it is envisaged that a sub-saturation level of PVME was required.


Membranes were prepared with concentrations as a proportion of the dope mixture of 0.1-0.2 wt % and their properties tested. There was no indication from any of the experiments of any thermal instability of PVME during extrusion of the membranes. Table 5 below shows the details of the different TIPS membranes.









TABLE 5







DETAILS OF TIPS MEMBRANES PREPARED WITH PVME IN DOPE














0.1 wt %
0.2 wt %
0.5 wt %
1 wt %
0.5 wt %




PVME
PVME
PVME
PVME
PVME
0.1 wt %

















Polymer Type
50/50
50/50
50/50
Solef
HALAR ®
HALAR ®



Solef 1015 -
Solef 1015 -
Solef 1015 -
1015
901
901



Kynar 461
Kynar
Kynar 450




460


Polymer
24
24
24
18
18
18


Conentration (wt %)


Solvent-
GTA -
GTA -
GTA -
GTA -
GTA
GTA


Non-solvent
Diethylene
Diethylene
Diethylene
Diethylene



glycol
glycol
glycol
glycol


Solv./Non-solv.
40:60
40:60
45:55
40:60
100
100


Ratio (wt %)


Coating Solvent
Triacetin
Citroflex 2
Triacetin
Triacetin
GTA
GTA


Coating Non-solvent
Diethylene
Triethylene
Citroflex 2
Diethylene





glycol
Glycol

glycol


Coating Solv./Non-
68:32
45:55
90:10
50:50
100
100


solv. Ratio (wt %)


Quench Type
Water
Water
PEG 200
Water
Water
Water


Break Extension (%)
152
228
35

156
173


Break Force/unit
5.1
7.08
2.98

5.94
5.59


area (N/mm2)


Permeability
4838
1440
301

1367
707


(LMH/bar)


Bubble Point (kPa)
250
390
460

450
200


Fibre Wicking
Partially
Yes
Yes
Yes











The differences between the structures of the membranes, as observed by SEM for the samples with and without PVME are only minor for 0.1 and 0.2 wt %. These can be seen in FIGS. 2 and 3. Slightly larger than average cells within the structure can be seen in the SEMs of samples that have been prepared with PVME. However at about 0.5 wt % some immiscibility is apparent and there is some de-mixing occurring. At the 1 wt % level this de-mixing has become more extreme. In the case of PVDF, this is most likely due to the high proportion of non-solvent used in the dope mixture to extrude the membrane fibres. In the case of Poly(ethylene-chlorotrifluoroethylene) sold under the trademark HALAR®, which can be seen in FIG. 4, demixing is most likely due to immiscibly with the base polymer (HALAR®) as there is no non-solvent present.


However such a high proportion of PVME does not appear to be necessary to impart hydrophilicity to the fibres. 0.1 wt % appears sufficient to commence hydrophilising the membrane, but at this level there appears to be some portions of the fibres that were not hydrophilic; that is to say that upon immersion in water only sections of the fibre could be seen to wet out, while some sections remained dry, but would wet with the assistance of ethanol. However, with 0.2 wt % PVME present in the fibre complete hydrophilisation appeared to have taken place.


It is also noted that higher proportions of PVME in the membrane appear to cause a greater degree of asymmetry, which up to a point is a desirable property in MF and IF membranes. Although the samples with 0.5 and 1 wt % PVME show evidence of de-mixing as discussed earlier, they also show a high degree of asymmetry which can be attributed directly to the PVME in the structure. In addition this de-mixing can be used to induce small pores by working as a nucleating agent and encouraging phase separation. The relationship between asymmetry and PVME content is demonstrated by the trend toward increasing bubble point as the PVME content increases.


In summary, incorporating PVME into the dope in TIPS trials was successful in imparting hydrophilicity to the membranes. The proportion of PVME used was most preferably between 0.1 and 0.5%, although this is dependent upon the amount of non solvent in the dope. If the proportion of non solvent used was lower than 60 wt %, a larger amount of PVME could be incorporated into the dope. However, the preferred range recited above is sufficient in most cases to begin to induce structural changes in the membrane such as asymmetry and smaller pores, as well as cause the membrane to be hydrophilic.


DIPS Membranes


Three dopes were prepared with the compositions listed in Table 6 below. Two different proportions of PVME (0.1 wt % and 2.5 wt %) were compared with a DIPS PVDF dope that contained poly(vinylpyrrolidone-vinylacetate) (S630) as an alternative additive. These fibres were all extruded in an identical manner and the results are compared below.












TABLE 6







0.4 wt %
2.3 wt %



Standard
PVME
PVME


















Dope Properties





PVDF Conc. (wt %)
13
13
13


S630 Conc. (wt %)
2.6
0
0


PVDF Conc. (wt %)
0
0.4
2.3


Pore Forming Agent Conc.
3
3
3


(wt %)





Water Conc. (wt %)
2
1.8
2.3


NPMP Conc. (wt %)
79.4
81.8
79.4


Fibre Properties





Break Extension (%)
182
217
260


Break Force (N)
0.78
1.03
1.32


Breack Force/mm2 (N/mm2)
3.81
4.83
4.12


Permeability (LMH/bar)
620
134
359


Bubble Point (kPa)
300
500
500


Fibre Wicking
Yes
Yes
Yes









The fibres show an increase in break extension, break force and bubble point by when PVME was added. Without wishing to be bound by theory, these increases may be partly due to a viscosity effect in that replacing S630 with PVME results in a more viscous dope which may in turn lead to fewer macrovoids and a more robust structure, giving a higher break force and break extension, and also possibly contributing to the increase in bubble point. The variation in permeability is possibly due to the change in water (non-solvent) concentration between the samples.


The SEMs in FIG. 5 demonstrate the trend apparent from the fibre properties—adding PVME to the structure decreases the formation of macrovoids. Less than a 0.4 wt % replacement of S630 with PVME is required to induce a dramatic change in properties however, as demonstrated by the DIPS examples.


All samples wicked water quite thoroughly, and there was no difference observed from the hydrophilicity of the standard formulation. The permeability measurements were conducted without a ‘wetting’ step—a manual wetting out of the membrane with ethanol. The permeability of 2.3 wt % PVME samples appears to increase over 0.4 wt % PVME samples. Since the bubble point is the same for these two samples while permeability varies, it can be seen that increasing the PVDF concentration and adding different PVME concentrations allow a UF membrane with a high permeability to be produced.

Claims
  • 1. A polymeric ultra or microfiltration membrane comprising poly(vinyl methyl ether) and at least one of poly(ethylene chlorotrifluoroethylene), polyvinylidene fluoride (PVDF), and polypropylene, wherein the poly(vinyl methyl ether) (PVME) is incorporated in the membrane as a homogeneous or heterogeneous dispersion throughout the membrane.
  • 2. The polymeric ultra or microfiltration membrane according to claim 1, wherein the PVME is incorporated in the membrane as a homogeneous dispersion throughout the membrane.
  • 3. The polymeric ultra or microfiltration membrane according to claim 1, wherein the PVME is incorporated in the membrane as a heterogeneous dispersion throughout the membrane.
  • 4. The polymeric ultra or microfiltration membrane according to claim 1, wherein the membrane is hydrophilic.
  • 5. The polymeric ultra or microfiltration membrane according to claim 1, comprising an asymmetric structure.
  • 6. The polymeric ultra or microfiltration membrane according to claim 1, having reduced pore size as a result of the addition of PVME.
  • 7. The polymeric ultra or microfiltration membrane according to claim 1, that is substantially free from macrovoids.
  • 8. The polymeric ultra or microfiltration membrane according to claim 1, wherein the membrane comprises cross-linked PVME.
  • 9. The polymeric ultra or microfiltration membrane according to claim 1, comprising PVDF and PVME in a ratio of 0.1:24 to 0.5:24.
  • 10. The polymeric ultra or microfiltration membrane according to claim 1, comprising poly(ethylene chlorotrifluoroethylene) and PVME in a ratio of 0.5:18 to 1:18.
  • 11. The polymeric ultra or microfiltration membrane according to claim 1, comprising PVDF and PVME in a ratio of 0.4:13 to 2.3:13.
  • 12. The polymeric ultra or microfiltration membrane according to claim 1, comprising 0.4 to 30 wt % PVME.
  • 13. The polymeric ultra or microfiltration membrane according to claim 1, wherein upon soaking for 8 hours produces a detectable quantity of PVME.
  • 14. The polymeric ultra or microfiltration membrane according to claim 1, wherein upon soaking for 48 hours produces a leachate having at least 5 ppm PVME.
  • 15. The polymeric ultra or microfiltration membrane according to claim 4, rendered hydrophilic by contacting the membrane with an aqueous or alcoholic solution of PVME with a concentration of 0.05 to 5 wt %.
  • 16. The polymeric ultra or microfiltration membrane according to claim 1, rendered hydrophilic by contacting the membrane with an aqueous or alcoholic solution of PVME with a concentration of 0.05 to 5 wt %, at a pressure of 0.5 to 50 bar.
Priority Claims (1)
Number Date Country Kind
2003903507 Jul 2003 AU national
CROSS REFERENCE TO RELATED APPLICATIONS

This application is a continuation of and claims priority to U.S. nonprovisional patent application Ser. No. 12/647,734 filed on Dec. 28, 2009 issued as U.S. Pat. No. 8,057,574 B2 on Nov. 15, 2011, titled MEMBRANE POST TREATMENT which is a continuation of and claims priority to U.S. nonprovisional patent application Ser. No. 10/564,024 filed on Jan. 9, 2006, issued as U.S. Pat. No. 7,662,212 B2 on Feb. 16, 2010 titled MEMBRANE POST TREATMENT which is a U.S. national stage application and claims the benefit under 35 U.S.C. §371 of International Application No. PCT/AU2004/000922 filed on Jul. 8, 2004, titled MEMBRANE POST TREATMENT, which is based on Australian Patent Application No. 2003903507 filed on Jul. 8, 2003, titled MEMBRANE POST TREATMENT, each of which is entirely incorporated herein by reference for all purposes, and to which this application claims the benefit of priority.

US Referenced Citations (319)
Number Name Date Kind
1994135 Horowitz Mar 1935 A
2658045 Schildknecht Nov 1953 A
3228876 Mahon Jan 1966 A
3275554 Wagenaar Sep 1966 A
3373056 Martin Mar 1968 A
3435893 Withers Apr 1969 A
3556305 Shorr Jan 1971 A
3625827 Wildi et al. Dec 1971 A
3654147 Levin Apr 1972 A
3693406 Tobin, III Sep 1972 A
3708071 Crowley Jan 1973 A
3728256 Cooper Apr 1973 A
3864289 Rendall Feb 1975 A
3876738 Marinaccio et al. Apr 1975 A
3968192 Hoffman, III et al. Jul 1976 A
3992301 Shippey et al. Nov 1976 A
3993816 Baudet et al. Nov 1976 A
4033817 Gregor Jul 1977 A
4142526 Zaffaroni et al. Mar 1979 A
4188817 Steigelmann Feb 1980 A
4192750 Elfes et al. Mar 1980 A
4193780 Cotton, Jr. et al. Mar 1980 A
4203848 Grandine, II May 1980 A
4218324 Hartmann et al. Aug 1980 A
4230583 Chiolle et al. Oct 1980 A
4247498 Castro Jan 1981 A
4248648 Kopp Feb 1981 A
4253936 Leysen et al. Mar 1981 A
4278548 Bettinger et al. Jul 1981 A
4302336 Kawaguchi et al. Nov 1981 A
4340479 Pall Jul 1982 A
4353802 Hara et al. Oct 1982 A
4354443 Abrahamson Oct 1982 A
4384474 Kowalski May 1983 A
4385150 Miyake et al. May 1983 A
4388189 Kawaguchi et al. Jun 1983 A
4407975 Yamaguchi Oct 1983 A
4431545 Pall et al. Feb 1984 A
4439217 Yamabe et al. Mar 1984 A
4451369 Sekino et al. May 1984 A
4511471 Muller Apr 1985 A
4519909 Castro May 1985 A
4540490 Shibata et al. Sep 1985 A
4547289 Okano et al. Oct 1985 A
4559139 Uemura et al. Dec 1985 A
4609465 Miller Sep 1986 A
4614109 Hofmann Sep 1986 A
4618533 Steuck Oct 1986 A
4623670 Mutoh et al. Nov 1986 A
4623690 Patzschke et al. Nov 1986 A
4629563 Wrasidlo Dec 1986 A
4632745 Giuffrida et al. Dec 1986 A
4636296 Kunz Jan 1987 A
4642182 Drori Feb 1987 A
4647377 Miura Mar 1987 A
4650586 Ellis, III Mar 1987 A
4650596 Schlueter et al. Mar 1987 A
4656865 Callan Apr 1987 A
4660411 Reid Apr 1987 A
4670145 Edwards Jun 1987 A
4673507 Brown Jun 1987 A
4687561 Kunz Aug 1987 A
4688511 Gerlach et al. Aug 1987 A
4695592 Itoh et al. Sep 1987 A
4702836 Mutoh et al. Oct 1987 A
4702840 Degen et al. Oct 1987 A
4707266 Degen et al. Nov 1987 A
4708799 Gerlach et al. Nov 1987 A
4718270 Storr Jan 1988 A
4735261 Huebner Apr 1988 A
4744240 Reichelt May 1988 A
4756875 Tajima et al. Jul 1988 A
4758251 Swedo et al. Jul 1988 A
4763612 Iwanami Aug 1988 A
4767539 Ford Aug 1988 A
4775471 Nagai et al. Oct 1988 A
4779448 Gogins Oct 1988 A
4784771 Wathen et al. Nov 1988 A
4793932 Ford et al. Dec 1988 A
4797187 Davis et al. Jan 1989 A
4797211 Ehrfeld et al. Jan 1989 A
4810384 Fabre Mar 1989 A
4812235 Seleman et al. Mar 1989 A
4816160 Ford et al. Mar 1989 A
4840227 Schmidt Jun 1989 A
4846970 Bertelsen et al. Jul 1989 A
4855163 Joffee et al. Aug 1989 A
4876006 Ohkubo et al. Oct 1989 A
4876012 Kopp et al. Oct 1989 A
4886601 Iwatsuka et al. Dec 1989 A
4886668 Haslam et al. Dec 1989 A
4888115 Marinaccio et al. Dec 1989 A
4892739 Shah et al. Jan 1990 A
4904426 Lundgard et al. Feb 1990 A
4909943 Fibiger et al. Mar 1990 A
4921610 Ford et al. May 1990 A
4931186 Ford et al. Jun 1990 A
4935143 Kopp et al. Jun 1990 A
4963304 Im et al. Oct 1990 A
4968733 Muller et al. Nov 1990 A
4999038 Lundberg Mar 1991 A
5005430 Kibler et al. Apr 1991 A
5015275 Beck et al. May 1991 A
5017292 DiLeo et al. May 1991 A
5019260 Gsell et al. May 1991 A
5024762 Ford et al. Jun 1991 A
5032282 Linder et al. Jul 1991 A
5043113 Kafchinski et al. Aug 1991 A
5049275 Gillberg-LaForce et al. Sep 1991 A
5066375 Parsi et al. Nov 1991 A
5066401 Muller et al. Nov 1991 A
5066402 Anselme et al. Nov 1991 A
5069065 Sprunt et al. Dec 1991 A
5075065 Effenberger et al. Dec 1991 A
5076925 Roesink et al. Dec 1991 A
5079272 Allegrezza, Jr. et al. Jan 1992 A
5094750 Kopp et al. Mar 1992 A
5104535 Cote et al. Apr 1992 A
5104546 Filson et al. Apr 1992 A
H1045 Wilson May 1992 H
5135663 Newberth, III et al. Aug 1992 A
5137631 Eckman et al. Aug 1992 A
5137633 Wang Aug 1992 A
5138870 Lyssy Aug 1992 A
5147553 Waite Sep 1992 A
5151191 Sunaoka et al. Sep 1992 A
5151193 Grobe et al. Sep 1992 A
5158721 Allegrezza, Jr. et al. Oct 1992 A
5182019 Cote et al. Jan 1993 A
5192456 Ishida et al. Mar 1993 A
5192478 Caskey Mar 1993 A
5194149 Selbie et al. Mar 1993 A
5198116 Comstock et al. Mar 1993 A
5198162 Park et al. Mar 1993 A
5209852 Sunaoka et al. May 1993 A
5211823 Giuffrida et al. May 1993 A
5221478 Dhingra et al. Jun 1993 A
5227063 Langerak et al. Jul 1993 A
5248424 Cote et al. Sep 1993 A
5275766 Gadkaree et al. Jan 1994 A
5286324 Kawai et al. Feb 1994 A
5288324 Shaneyfelt Feb 1994 A
5297420 Gilliland et al. Mar 1994 A
5320760 Freund et al. Jun 1994 A
5353630 Soda et al. Oct 1994 A
5354587 Abayasekara Oct 1994 A
5361625 Ylvisaker Nov 1994 A
5364527 Zimmermann et al. Nov 1994 A
5376274 Muller et al. Dec 1994 A
5389260 Hemp et al. Feb 1995 A
5396019 Sartori et al. Mar 1995 A
5401401 Hickok et al. Mar 1995 A
5403479 Smith et al. Apr 1995 A
5403483 Hayashida et al. Apr 1995 A
5405528 Selbie et al. Apr 1995 A
5411663 Johnson May 1995 A
5417101 Weich May 1995 A
5419816 Sampson et al. May 1995 A
5451317 Ishida et al. Sep 1995 A
5470469 Eckman Nov 1995 A
5477731 Mouton Dec 1995 A
5480553 Yamamori et al. Jan 1996 A
5491023 Tsai et al. Feb 1996 A
5525220 Yagi et al. Jun 1996 A
5531848 Brinda et al. Jul 1996 A
5531900 Raghavan et al. Jul 1996 A
5543002 Brinda et al. Aug 1996 A
5543465 Bell et al. Aug 1996 A
5547575 Demmer et al. Aug 1996 A
5554283 Brinda et al. Sep 1996 A
5607593 Cote et al. Mar 1997 A
5629084 Moya May 1997 A
5639373 Mahendran et al. Jun 1997 A
5643455 Kopp et al. Jul 1997 A
5647988 Kawanishi et al. Jul 1997 A
5725769 Miller et al. Mar 1998 A
5747605 Breant et al. May 1998 A
D396046 Scheel et al. Jul 1998 S
D396477 Sadr Jul 1998 S
5783083 Henshaw et al. Jul 1998 A
D400890 Gambardella Nov 1998 S
5871823 Anders et al. Feb 1999 A
5906742 Wang et al. May 1999 A
5910250 Mahendran et al. Jun 1999 A
5914039 Mahendran et al. Jun 1999 A
5918264 Drummond et al. Jun 1999 A
5942113 Morimura Aug 1999 A
5944997 Pedersen et al. Aug 1999 A
5958243 Lawrence et al. Sep 1999 A
5981614 Adiletta Nov 1999 A
5988400 Karachevtcev et al. Nov 1999 A
6024872 Mahendran et al. Feb 2000 A
6039872 Wu et al. Mar 2000 A
6042677 Mahendran et al. Mar 2000 A
6045698 Cote et al. Apr 2000 A
6045899 Wang et al. Apr 2000 A
6048454 Jenkins Apr 2000 A
6056903 Greenwood et al. May 2000 A
6074718 Puglia et al. Jun 2000 A
6077435 Beck et al. Jun 2000 A
6083393 Wu et al. Jul 2000 A
6096213 Radovanovic et al. Aug 2000 A
6113794 Kumar et al. Sep 2000 A
6146747 Wang et al. Nov 2000 A
6156200 Zha et al. Dec 2000 A
6159369 Strohm et al. Dec 2000 A
6159373 Beck et al. Dec 2000 A
6193890 Pedersen et al. Feb 2001 B1
6202475 Selbie et al. Mar 2001 B1
6214231 Cote et al. Apr 2001 B1
6221247 Nemser et al. Apr 2001 B1
6245239 Cote et al. Jun 2001 B1
6254773 Biltoft Jul 2001 B1
6264839 Mohr et al. Jul 2001 B1
6277512 Hamrock et al. Aug 2001 B1
6280626 Miyashita et al. Aug 2001 B1
6284135 Ookata Sep 2001 B1
6294039 Mahendran et al. Sep 2001 B1
6299773 Takamura et al. Oct 2001 B1
6315895 Summerton et al. Nov 2001 B1
6322703 Taniguchi et al. Nov 2001 B1
6325928 Pedersen et al. Dec 2001 B1
6337018 Mickols Jan 2002 B1
RE37549 Mahendran et al. Feb 2002 E
6354444 Mahendran et al. Mar 2002 B1
6375848 Cote et al. Apr 2002 B1
6423784 Hamrock et al. Jul 2002 B1
6440303 Spriegel Aug 2002 B2
D462699 Johnson et al. Sep 2002 S
6448062 Huth et al. Sep 2002 B1
6465748 Yamanashi et al. Oct 2002 B2
6491165 Kuske et al. Dec 2002 B2
6495041 Taniguchi et al. Dec 2002 B2
6524481 Zha et al. Feb 2003 B2
6550747 Rabie et al. Apr 2003 B2
6555005 Zha et al. Apr 2003 B1
6596167 Ji et al. Jul 2003 B2
D478913 Johnson et al. Aug 2003 S
6602391 Serikov Aug 2003 B2
6620319 Behmann et al. Sep 2003 B2
6635104 Komkova et al. Oct 2003 B2
6635179 Summerton et al. Oct 2003 B1
6641733 Zha et al. Nov 2003 B2
6645374 Cote et al. Nov 2003 B2
6656356 Gungerich et al. Dec 2003 B2
6682652 Mahendran et al. Jan 2004 B2
6685832 Mahendran et al. Feb 2004 B2
6699611 Kim et al. Mar 2004 B2
6705465 Ling et al. Mar 2004 B2
6721529 Chen et al. Apr 2004 B2
6723246 Krulik Apr 2004 B2
6723758 Stone et al. Apr 2004 B2
6727305 Pavez Aranguiz Apr 2004 B1
6761013 Tippey et al. Jul 2004 B2
6770202 Kidd et al. Aug 2004 B1
6783008 Zha et al. Aug 2004 B2
6790912 Blong Sep 2004 B2
6793820 McCray et al. Sep 2004 B1
6811696 Wang et al. Nov 2004 B2
6821420 Zha et al. Nov 2004 B2
6830782 Kanazawa Dec 2004 B2
6851259 Simburger et al. Feb 2005 B2
6861466 Dadalas et al. Mar 2005 B2
6872305 Johnson et al. Mar 2005 B2
6884350 Muller Apr 2005 B2
6884375 Wang et al. Apr 2005 B2
6890435 Ji et al. May 2005 B2
6890645 Disse et al. May 2005 B2
6893568 Janson et al. May 2005 B1
6969465 Zha et al. Nov 2005 B2
6974554 Cox et al. Dec 2005 B2
6994867 Hossainy et al. Feb 2006 B1
7000764 Otsubo Feb 2006 B2
7041728 Zipplies et al. May 2006 B2
7070909 Japp et al. Jul 2006 B2
7226541 Muller et al. Jun 2007 B2
7247238 Mullette et al. Jul 2007 B2
7300022 Muller Nov 2007 B2
7390418 Martin et al. Jun 2008 B2
7395646 Salman et al. Jul 2008 B2
7404896 Muller Jul 2008 B2
7449112 Lee et al. Nov 2008 B2
7459085 Koguma et al. Dec 2008 B2
7537718 Mezhirov et al. May 2009 B2
7632439 Mullette et al. Dec 2009 B2
7648034 Charkoudian et al. Jan 2010 B2
7662212 Mullette et al. Feb 2010 B2
7819956 Muller Oct 2010 B2
7867417 Mullette Jan 2011 B2
20020104439 Komkova et al. Aug 2002 A1
20020148767 Johnson et al. Oct 2002 A1
20030065302 Kuroda et al. Apr 2003 A1
20030073970 Suga Apr 2003 A1
20030178365 Zha et al. Sep 2003 A1
20030226797 Phelps Dec 2003 A1
20040084369 Zha et al. May 2004 A1
20040092901 Reece et al. May 2004 A1
20040145076 Zha et al. Jul 2004 A1
20040167490 Nelson et al. Aug 2004 A1
20040167493 Jarpenberg et al. Aug 2004 A1
20040168947 McDonald Sep 2004 A1
20040172002 Nelson et al. Sep 2004 A1
20040176735 Snell Sep 2004 A1
20040195172 Yeh et al. Oct 2004 A1
20040217053 Zha et al. Nov 2004 A1
20050015052 Klippen et al. Jan 2005 A1
20050029185 Muller Feb 2005 A1
20050032982 Muller Feb 2005 A1
20050098494 Mullette et al. May 2005 A1
20050218069 Lee et al. Oct 2005 A1
20060157404 Mullette et al. Jul 2006 A1
20060178480 Tada et al. Aug 2006 A1
20060228483 Abidine Oct 2006 A1
20070007197 Mahendran et al. Jan 2007 A1
20070107884 Sirkar et al. May 2007 A1
20080058440 Muller et al. Mar 2008 A1
20080203018 Muller et al. Aug 2008 A1
20080214687 Muller et al. Sep 2008 A1
20100213117 Mullette et al. Aug 2010 A1
Foreign Referenced Citations (140)
Number Date Country
897069 Apr 1972 CA
2428457 May 2002 CA
2440961 Sep 2002 CA
1159770 Sep 1997 CN
1552507 Dec 2004 CN
3904544 Aug 1990 DE
4007383 Sep 1991 DE
4117281 Jan 1992 DE
4113420 Oct 1992 DE
4117422 Nov 1992 DE
19503060 Aug 1996 DE
29906389 Jun 1999 DE
012557 Feb 1983 EP
050447 Oct 1985 EP
250337 Dec 1987 EP
261734 Mar 1988 EP
407900 Jan 1991 EP
419396 Mar 1991 EP
229019 Sep 1991 EP
463627 Jan 1992 EP
492942 Jul 1992 EP
509663 Oct 1992 EP
550798 Jul 1993 EP
395133 Feb 1995 EP
492446 Nov 1995 EP
430082 Jun 1996 EP
581168 Oct 1996 EP
763758 Mar 1997 EP
911073 Apr 1999 EP
920904 Jun 1999 EP
1034835 Sep 2000 EP
1052012 Nov 2000 EP
1236503 Aug 2004 EP
2620712 Mar 1989 FR
2674448 Oct 1992 FR
2850297 Jul 2004 FR
702911 Jan 1954 GB
2253572 Sep 1992 GB
2390042 Dec 2003 GB
53-028083 Mar 1978 JP
55129155 Oct 1980 JP
58088007 May 1983 JP
60260628 Dec 1985 JP
61097006 May 1986 JP
61107905 May 1986 JP
61192309 Aug 1986 JP
61257203 Nov 1986 JP
61263605 Nov 1986 JP
62004408 Jan 1987 JP
62068828 Mar 1987 JP
62114609 May 1987 JP
62140607 Jun 1987 JP
62179540 Aug 1987 JP
62250908 Oct 1987 JP
63097634 Apr 1988 JP
S63-38884 Oct 1988 JP
64-075542 Mar 1989 JP
01-307409 Dec 1989 JP
2009498 Jan 1990 JP
02031200 Feb 1990 JP
02144132 Jun 1990 JP
02164423 Jun 1990 JP
02284035 Nov 1990 JP
02302449 Dec 1990 JP
03018373 Jan 1991 JP
03110445 May 1991 JP
03186325 Aug 1991 JP
04022428 Jan 1992 JP
04187224 Jul 1992 JP
04250898 Sep 1992 JP
04265128 Sep 1992 JP
04293528 Oct 1992 JP
04300636 Oct 1992 JP
04310223 Nov 1992 JP
05023557 Feb 1993 JP
05-96140 Apr 1993 JP
05096136 Apr 1993 JP
05115760 May 1993 JP
05131124 May 1993 JP
05157654 Jun 1993 JP
05285348 Nov 1993 JP
06-027215 Feb 1994 JP
06071120 Mar 1994 JP
06114240 Apr 1994 JP
06218237 Aug 1994 JP
06285496 Oct 1994 JP
06343837 Dec 1994 JP
07000770 Jan 1995 JP
07003043 Jan 1995 JP
07024272 Jan 1995 JP
07155570 Jun 1995 JP
07155758 Jun 1995 JP
07185268 Jul 1995 JP
07185271 Jul 1995 JP
07275665 Oct 1995 JP
08010585 Jan 1996 JP
08052331 Feb 1996 JP
09141063 Jun 1997 JP
09220569 Aug 1997 JP
09324067 Dec 1997 JP
09512857 Dec 1997 JP
10156149 Jun 1998 JP
11152366 Jun 1999 JP
11165200 Jun 1999 JP
11302438 Nov 1999 JP
2000342932 Dec 2000 JP
2004230280 Aug 2004 JP
2004523338 Aug 2004 JP
2005-514517 May 2005 JP
2005154551 Jun 2005 JP
2005-537120 Dec 2005 JP
2006517469 Jul 2006 JP
2002061017 Jul 2002 KR
8806200 Aug 1988 WO
9000434 Jan 1990 WO
9117204 Nov 1991 WO
9302779 Feb 1993 WO
9315827 Aug 1993 WO
9534424 Dec 1995 WO
9603202 Feb 1996 WO
9607470 Mar 1996 WO
9614913 May 1996 WO
9641676 Dec 1996 WO
9822204 May 1998 WO
9825694 Jun 1998 WO
9828066 Jul 1998 WO
9901207 Jan 1999 WO
0043115 Jul 2000 WO
0238256 May 2002 WO
02087734 Nov 2002 WO
03068374 Aug 2003 WO
03080228 Oct 2003 WO
03095078 Nov 2003 WO
2004078327 Sep 2004 WO
2004094049 Nov 2004 WO
2005002712 Jan 2005 WO
2005005028 Jan 2005 WO
2005030916 Apr 2005 WO
2006002479 Jan 2006 WO
2006058384 Jun 2006 WO
Related Publications (1)
Number Date Country
20110290717 A1 Dec 2011 US
Continuations (2)
Number Date Country
Parent 12647734 Dec 2009 US
Child 13206845 US
Parent 10564024 US
Child 12647734 US